AR016261A1 - Compuestos de eter de morfolino, proceso para su preparacion, uso para la preparacion de medicamentos, composicion farmaceutica - Google Patents

Compuestos de eter de morfolino, proceso para su preparacion, uso para la preparacion de medicamentos, composicion farmaceutica

Info

Publication number
AR016261A1
AR016261A1 ARP990102128A ARP990102128A AR016261A1 AR 016261 A1 AR016261 A1 AR 016261A1 AR P990102128 A ARP990102128 A AR P990102128A AR P990102128 A ARP990102128 A AR P990102128A AR 016261 A1 AR016261 A1 AR 016261A1
Authority
AR
Argentina
Prior art keywords
optionally substituted
straight
alkoxy
branched
preparation
Prior art date
Application number
ARP990102128A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Wellcome Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Sa filed Critical Glaxo Wellcome Sa
Publication of AR016261A1 publication Critical patent/AR016261A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ARP990102128A 1998-05-11 1999-05-06 Compuestos de eter de morfolino, proceso para su preparacion, uso para la preparacion de medicamentos, composicion farmaceutica AR016261A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98500117 1998-05-11
EP98500204 1998-09-18

Publications (1)

Publication Number Publication Date
AR016261A1 true AR016261A1 (es) 2001-06-20

Family

ID=26151831

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102128A AR016261A1 (es) 1998-05-11 1999-05-06 Compuestos de eter de morfolino, proceso para su preparacion, uso para la preparacion de medicamentos, composicion farmaceutica

Country Status (13)

Country Link
EP (1) EP1077959A1 (zh)
JP (1) JP2002514632A (zh)
KR (1) KR100625146B1 (zh)
CN (1) CN1174971C (zh)
AR (1) AR016261A1 (zh)
AU (1) AU763088B2 (zh)
BR (1) BR9910377A (zh)
CA (1) CA2331584A1 (zh)
MA (1) MA26628A1 (zh)
PE (1) PE20000479A1 (zh)
TR (1) TR200003301T2 (zh)
TW (1) TW585858B (zh)
WO (1) WO1999058512A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286208A1 (en) * 2000-09-13 2002-03-26 Sankyo Company Limited Zofimarin derivatives having oxazepam ring
RU2259825C9 (ru) 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
JP6640750B2 (ja) * 2015-01-30 2020-02-05 日油株式会社 カチオン性脂質

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
HU218611B (hu) * 1994-11-08 2000-10-28 Glaxo Wellcome S.A. Gombaölő hatású szordarinszármazékok, ezeket tartalmazó gyógyszerkészítmények, a vegyületek előállítása és alkalmazása
EP0712859A1 (en) * 1994-11-08 1996-05-22 Glaxo, S.A. Antifungal Sordarin derivatives
EP0711784A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives
EP0711783A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives
US6177457B1 (en) * 1996-05-08 2001-01-23 Glaxo Wellcome S.A. Process for the preparation of indacene compound
EP0938307B1 (en) * 1996-09-18 2003-05-07 Merck & Co., Inc. Sordarin and derivatives thereof for use as crop antifungal agents
DE69727948T2 (de) * 1996-10-07 2005-02-10 Merck & Co., Inc. Sordarinderivate
EA002644B1 (ru) * 1997-08-22 2002-08-29 Мерк Энд Ко., Инк. Производные 4-циано-4-деформилсордарицина
AU740477B2 (en) * 1997-08-22 2001-11-08 Merck Sharp & Dohme Corp. 4-cyano-4-deformylsordarin derivatives

Also Published As

Publication number Publication date
CN1174971C (zh) 2004-11-10
WO1999058512A1 (en) 1999-11-18
CA2331584A1 (en) 1999-11-18
TR200003301T2 (tr) 2001-02-21
PE20000479A1 (es) 2000-05-29
MA26628A1 (fr) 2004-12-20
JP2002514632A (ja) 2002-05-21
CN1309651A (zh) 2001-08-22
TW585858B (en) 2004-05-01
AU4258899A (en) 1999-11-29
BR9910377A (pt) 2001-01-16
KR100625146B1 (ko) 2006-09-20
EP1077959A1 (en) 2001-02-28
AU763088B2 (en) 2003-07-10
KR20010025009A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
MX9404749A (es) Heterociclos de fenilo como inhibidores de cox-2.
PT81586B (pt) Processo para a preparacao de derivados de benzoxazol e benzotiazolamina e de composicoes farmaceuticas que os contem
BRPI0412527A (pt) composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto.
AR035617A1 (es) Compuestos derivados de fenetanolamina, combinaciones y formulaciones farmaceuticas de los mismos, proceso para su preparacion, su uso en la preparacion de medicamentos para el tratamiento o profilaxis de una condicion clinica para la cual se indica un agonista beta2 adreno-receptor e intermediarios
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
DK0590267T3 (da) Desoxy-taxolderivater
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
CY1110261T1 (el) Παραγωγα της κουμαρινης που χρησιμοποιουνται σαν αντιπηκτικα
AR051771A1 (es) Acidos amino carboxilicos sustituidos
BR0315580A (pt) Derivados de metileno uréia
BRPI0408727A (pt) composto, processo para preparar o mesmo, composição farmacêutica, método para tratar de uma condição ou estado de doença mediados pela atividade da quinase p38 ou mediados pelas citocinas produzidas pela atividade da quinase p38, e, uso de um composto
CY1111980T1 (el) Παραγωγα του αμιδιου τα οποια φερουν ενα υποκαταστατο του κυκλοπροπυλαμινοκαρβονυλιου και χρησιμευουν ως αναστολεις κυτταροκινης
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
CY1107753T1 (el) 2,5-δισυποκατεστημενο 3-μερκαπτοπεντανοϊκο οξυ
ES2038172T3 (es) Procedimiento para preparar carboxamidas heterociclicas.
AR016261A1 (es) Compuestos de eter de morfolino, proceso para su preparacion, uso para la preparacion de medicamentos, composicion farmaceutica
AR044869A1 (es) Compuesto de dicetopiperazina, composicion farmaceutica que lo comprende, su uso para fabricar un medicamento y procedimiento para su preparacion
AR042547A1 (es) Uso de acidos alfa - feniltiocaboxilico y alfa - feniloxicarboxilico con actividad disminuidora de la glucosa en el suero y de los lipidos en el suero
CY1106396T1 (el) Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν
ES2058148T3 (es) N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos.
BRPI0408423A (pt) composições farmacêuticas compreendendo uma combinação de rapamicina ou seus derivados e pimecrolimus para o tratamento de doenças mediadas imunologicamente e por inflamação
SE9001269D0 (sv) 2-substituted n,n-ditrimethoxybenzoyl piperazines,a preparation process of the same and therapeutic compositions containing them
IT1266571B1 (it) Derivati della beta-mercapto-propanammide utili nel trattamento delle malattie cardiovascolari
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции

Legal Events

Date Code Title Description
FA Abandonment or withdrawal